New study to track cancer risk in rare genetic condition
NCT ID NCT05630105
First seen Jan 11, 2026 · Last updated May 15, 2026 · Updated 22 times
Summary
This study follows 430 people with Cowden's disease (a PTEN gene mutation) to see how often they develop cancer. Researchers will track any cancers, especially breast and thyroid, over time. The goal is to better understand cancer risks in this group to improve future monitoring and care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PTEN GENE MUTATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
1-CHU Amiens
Amiens, France
-
10-CHU Colmar
Colmar, France
-
11-CHU Dijon
Dijon, France
-
12-CHU Grenoble
Grenoble, France
-
13a-AP-HP Hôpital Avicenne
Paris, France
-
13b-AP-HP Hôpital Saint-Antoine
Paris, France
-
13c-APH-HP Hôpital Salpétrière
Paris, France
-
13d-AP-HP Hôpital Trousseau
Paris, France
-
13e-AP-HP Hôpital Saint-Louis
Paris, France
-
13f-AP-HP Hôpital Robert Debré
Paris, France
-
14-Institut Curie
Paris, France
-
15-Institut Gustave Roussy
Villejuif, France
-
16-CHU Lille
Lille, France
-
17-CHU Limoges
Limoges, France
-
18a-Hospices Civils Lyon - Lyon Est
Lyon, France
-
18b-Hospices Civils Lyon - Lyon Sud
Lyon, France
-
19-AP-HM Hôpital de la Timone
Marseille, France
-
2-CHU Angers
Angers, France
-
20-CHU Montpellier
Montpellier, France
-
21-CHU Nantes
Nantes, France
-
22-CHU Nice
Nice, France
-
23-CHU Nîmes
Nîmes, France
-
24-CHU Poitiers
Poitiers, France
-
25-Institut du Cancer Courlancy
Reims, France
-
26-Centre Eugène Marquis
Rennes, France
-
27-CHU Rennes
Rennes, France
-
28-CHU Saint-Etienne
Saint-Etienne, France
-
29-Institut Strauss
Strasbourg, France
-
3-ICO Angers et Nantes
Angers, France
-
30-CHU Toulouse
Toulouse, France
-
31-CHU Tours
Tours, France
-
32-Centre Antoine Lacassagne
Nice, France
-
33-Institut Paoli Calmettes
Marseille, France
-
34-CH Valence
Valence, France
-
35-CHU Rouen
Rouen, France
-
36-CH Le Mans
Le Mans, France
-
37-CH Niort
Niort, France
-
38-CHU Guadeloupe
Pointe à Pitre, France
-
4-CHU Besançon
Besançon, France
-
40-CHU Troyes
Troyes, France
-
5-CHU Bordeaux
Bordeaux, France
-
6-Institut Bergonié
Bordeaux, France
-
7-CHU Brest
Brest, France
-
8-Centre François Baclesse
Caen, France
-
9-CH Métropole Savoie Chambéry
Chambéry, France
Conditions
Explore the condition pages connected to this study.